BARCLAYS PLC - INVIVO THERAPEUTICS HLDGS CO ownership

Back to all holdings Add to watchlist

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 65 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q3 2016. The put-call ratio across all filers is 4.12 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
BARCLAYS PLC ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2018$0
-100.0%
2
-99.9%
0.00%–
Q1 2017$14,000
-39.1%
3,248
-4.5%
0.00%–
Q3 2016$23,000
+2200.0%
3,402
+2365.2%
0.00%–
Q3 2015$1,000
-87.5%
138
-72.8%
0.00%–
Q2 2015$8,000–508–0.00%–
 Download
Other shareholders

There were no reported owners of INVIVO THERAPEUTICS HLDGS CO in Q3 2016.

NameSharesValueWeighting ↓
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders